Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Lescoat

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Journal of Scleroderma and Related Disorders|February 6, 2023
Very Early Diagnosis of Systemic Sclerosis: Deciphering the heterogeneity of systemic sclerosis in the very early stages of the diseaseAlain Lescoat
Lancet (London, England)|October 31, 2017
From (re-)framing NCDs to shaping public health policies on NCDs and communicable diseasesCatherine Cavalin, Alain Lescoat
The Lancet. Global Health|October 14, 2017
Reframing non-communicable diseasesCatherine Cavalin, Alain Lescoat
Current Opinion in Rheumatology|March 20, 2021
Treatment for systemic sclerosis-associated interstitial lung diseaseDavid Roofeh, Alain Lescoat, Dinesh Khanna
Current Opinion in Rheumatology|August 31, 2023
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approachesAlain Lescoat, Hiroshi Kato, John Varga
Expert Opinion on Emerging Drugs|May 18, 2026
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapiesAlain Lescoat, Eisha Naveed, Dinesh Khanna
Molecular Aspects of Medicine|February 7, 2024
Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosisDavid Abraham, Alain Lescoat, Richard Stratton
Expert Opinion on Emerging Drugs|October 15, 2020
Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trialsDavid Roofeh, Alain Lescoat, Dinesh Khanna
Annals of the Rheumatic Diseases|February 15, 2018
M-CSF and GM-CSF monocyte-derived macrophages in systemic sclerosis: the two sides of the same coin?Alain Lescoat, Patrick Jégo, Valérie Lecureur
International Journal of Epidemiology|July 15, 2021
Occupational exposure to respirable crystalline silica and autoimmunity: sex differences in mouse modelsAlain Lescoat, Alice Ballerie, Valérie Lecureur
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Journal of Scleroderma and Related Disorders|February 6, 2023
Very Early Diagnosis of Systemic Sclerosis: Deciphering the heterogeneity of systemic sclerosis in the very early stages of the diseaseAlain Lescoat
Lancet (London, England)|October 31, 2017
From (re-)framing NCDs to shaping public health policies on NCDs and communicable diseasesCatherine Cavalin, Alain Lescoat
The Lancet. Global Health|October 14, 2017
Reframing non-communicable diseasesCatherine Cavalin, Alain Lescoat
Current Opinion in Rheumatology|March 20, 2021
Treatment for systemic sclerosis-associated interstitial lung diseaseDavid Roofeh, Alain Lescoat, Dinesh Khanna
Current Opinion in Rheumatology|August 31, 2023
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approachesAlain Lescoat, Hiroshi Kato, John Varga
Expert Opinion on Emerging Drugs|May 18, 2026
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapiesAlain Lescoat, Eisha Naveed, Dinesh Khanna
Molecular Aspects of Medicine|February 7, 2024
Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosisDavid Abraham, Alain Lescoat, Richard Stratton
Expert Opinion on Emerging Drugs|October 15, 2020
Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trialsDavid Roofeh, Alain Lescoat, Dinesh Khanna
Annals of the Rheumatic Diseases|February 15, 2018
M-CSF and GM-CSF monocyte-derived macrophages in systemic sclerosis: the two sides of the same coin?Alain Lescoat, Patrick Jégo, Valérie Lecureur
International Journal of Epidemiology|July 15, 2021
Occupational exposure to respirable crystalline silica and autoimmunity: sex differences in mouse modelsAlain Lescoat, Alice Ballerie, Valérie Lecureur
Pageof 15